Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

Expert Opinion on Drug Metabolism & Toxicology
Marcella MartignoniRuben de Kanter

Abstract

Animal models are commonly used in the preclinical development of new drugs to predict the metabolic behaviour of new compounds in humans. It is, however, important to realise that humans differ from animals with regards to isoform composition, expression and catalytic activities of drug-metabolising enzymes. In this review the authors describe similarities and differences in this respect among the different species, including man. This may be helpful for drug researchers to choose the most relevant animal species in which the metabolism of a compound can be studied for extrapolating the results to humans. The authors focus on CYPs, which are the main enzymes involved in numerous oxidative reactions and often play a critical role in the metabolism and pharmacokinetics of xenobiotics. In addition, induction and inhibition of CYPs are compared among species. The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well. In contrast, the species-specific isoforms of CYP1A, -2C, -2D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metabolism data from animal models to humans.

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Apr 6, 1992·Biochimica Et Biophysica Acta·T YanagimotoT Kamataki
Nov 1, 1992·The Journal of Clinical Investigation·J C KolarsP B Watkins
Jan 1, 1991·Clinical Pharmacology and Therapeutics·E SkjelboL F Gram
Apr 1, 1990·Alcoholism, Clinical and Experimental Research·R TsutsumiC S Lieber
Jun 1, 1990·British Journal of Clinical Pharmacology·D SesardicD S Davies
Jan 1, 1990·Pharmacology & Therapeutics·A B Okey
May 1, 1989·Biochemical Pharmacology·W H Peters, P G Kremers
Jan 1, 1988·Clinical Pharmacokinetics·T K Daneshmend, D W Warnock
Jul 1, 1987·Clinical Pharmacology and Therapeutics·S ToonM Rowland
Jan 1, 1985·Clinical Pharmacokinetics·T M Ludden
Oct 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·R L Dedrick
Feb 1, 1983·Toxicology and Applied Pharmacology·C HétuJ G Joly
Apr 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum
Mar 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S J BaldwinR J Chenery
Oct 29, 1993·Biochemical and Biophysical Research Communications·M Komori
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Jan 1, 1995·British Journal of Clinical Pharmacology·Z LiuA Rane
Dec 1, 1994·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·V Nedelcheva, I Gut
Feb 21, 1995·Biochimica Et Biophysica Acta·D StrotkampW G Hanstein
Oct 1, 1994·Pharmacogenetics·J C KolarsP B Watkins
Mar 8, 1994·Biochimica Et Biophysica Acta·T MatsunagaH Yoshimura
Dec 1, 1993·Archives of Biochemistry and Biophysics·S Kirita, T Matsubara

❮ Previous
Next ❯

Citations

Apr 30, 2010·Pharmaceutical Research·Cuyue Tang, Thomayant Prueksaritanont
Jun 12, 2013·Transgenic Research·Tatiana FlisikowskaAngelika Schnieke
May 16, 2013·European Journal of Drug Metabolism and Pharmacokinetics·Nuggehally R Srinivas
Feb 13, 2013·Biochemical Pharmacology·Gang XieBasil Rigas
Dec 21, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Nan MeiTao Chen
Feb 10, 2010·Omics : a Journal of Integrative Biology·Lei GuoPeter P Fu
Aug 28, 2012·Rheumatology·Sang-Won LeeBeom Seok Kim
Mar 31, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Darrell R BoverhofB Bhaskar Gollapudi
May 7, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Qiang ShiWilliam F Salminen
Aug 4, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rogelio Tornero-VelezMichael F Hughes
Jan 30, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Barbara A WetmoreRussell S Thomas
Oct 26, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kwi Hye KohHyunyoung Jeong
Jun 6, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Karelle MénochetAleksandra Galetin
Oct 5, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Dan YaoChi Chen
Nov 24, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Diana L ShusterQingcheng Mao
Aug 7, 2008·The Journal of Pharmacology and Experimental Therapeutics·Connie Cheung, Frank J Gonzalez
Mar 23, 2011·The Journal of Pharmacology and Experimental Therapeutics·Gang XieBasil Rigas
Feb 7, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jose Gomez-ArroyoNorbert F Voelkel
Jul 10, 2012·BMC Medical Ethics·Ray GreekLawrence A Hansen
Jan 12, 2008·Endocrinology·Xiaochao MaFrank J Gonzalez
Aug 13, 2013·PloS One·Stephanie EidAssaad A Eid
Oct 28, 2010·Drug Metabolism and Pharmacokinetics·Thomas A Baillie, Allan E Rettie
Nov 10, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alberto CorsiniMichele Bortolini
May 15, 2009·Regenerative Medicine·Ana KrtolicaRichard K Miller
Jun 8, 2011·Future Medicinal Chemistry·Leposava Antonovic, Marilyn Martinez
Sep 24, 2013·Biochemical Pharmacology·Jianghong Fan, Inés A M de Lannoy
Aug 21, 2013·Biochemical Pharmacology·Paul McGonigle, Bruce Ruggeri
Jan 5, 2014·BMC Complementary and Alternative Medicine·Sixun GuoGaofeng Liu
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Robert DallmannFrédéric Gachon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.